Back to Journals » Drug, Healthcare and Patient Safety » Volume 3

Complications in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS): analysis of 7-year physician-reported adverse events

Authors Niv Y, Gershtanski Y, Kenett R, Yossi Tal, Birkenfeld S

Published 21 June 2011 Volume 2011:3 Pages 21—25


Review by Single-blind

Peer reviewer comments 2

Yaron Niv1, Yael Gershtansky2, Ron S Kenett3, Yossi Tal2, Shlomo Birkenfeld4
1Department of Gastroenterology, Rabin Medical Center, Petach Tikva, Israel; 2Medical Risk Management, The Madanes Group, Tel Aviv, Israel; 3The KPA Group, University of Torino, Turin, Italy; 4Clalit Health Services, Tel Aviv, Israel

Introduction: The number of malpractice claims against physicians and health institutes is increasing continuously in Israel as in the rest of the Western world, and has become a serious financial burden.
Aim: In this study we analyzed the reports of gastroenterologists on endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) adverse events to the risk management authority between January 1, 2000 and December 31, 2006.
Methods: All the reported adverse events associated with ERCP and EUS of health institutes and covered by Madanes Insurance Agency were summarized and analyzed. Clinical and epidemiological details about the patients, procedures, and adverse events were coded into an Excel worksheet, discussed, and evaluated.
Results: Forty-two cases of ERCP and EUS adverse events were reported. There were nine cases of men (21.4%) and the average age was 69.3 ± 14.3 years. During this period, 10,647 procedures were performed by the institutes concerned and the number of adverse events was 20.2 to 67.8 per year for 10,000 procedures. Perforation occurred in one out of 367 procedures, bleeding in one out of 5323 procedures, teeth trauma in one out of 5323 procedures, and respiratory complications in one out of 10,647 procedures.
Conclusion: This is the first study in Israel about physicians' reports of ERCP and EUS adverse events. Physicians reported only about severe adverse events with high rate of mortality and morbidity.

Keywords: ERCP, EUS, defensive medicine, perforation, bleeding, sedation, risk management, patient safety

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Readers of this article also read:

Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

Hernández-Ojeda J, Román-Pintos LM, Rodríguez-Carrízalez AD, Troyo-Sanromán R, Cardona-Muñoz EG, Alatorre-Carranza MP, Miranda-Díaz AG

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:401-407

Published Date: 4 September 2014

Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance

Maekawa S, Kawahara T, Nomura R, Murase T, Ann Y, Oeholm M, Harada M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:195-201

Published Date: 13 June 2014

Communicable disease-related sudden death in the 21st century in Nigeria

Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA

Infection and Drug Resistance 2013, 6:125-132

Published Date: 7 October 2013

Prescribing tests must have curriculum support

Lemon TI, Shah RD

Advances in Medical Education and Practice 2013, 4:91-93

Published Date: 7 May 2013

Clinical and behavioral factors associated with management outcome in hospitalized patients with diabetic foot ulcer

Yekta Z, Pourali R, Nezhadrahim R, Ravanyar L, Ghasemi-rad M

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:371-375

Published Date: 13 October 2011

Exenatide improves glucocorticoid-induced glucose intolerance in mice

Ruiying Zhao, Enrique Fuentes-Mattei, Guermarie Velazquez-Torres, et al

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011, 4:61-65

Published Date: 26 January 2011

Differential effects of amyloid-beta peptide aggregation status on in vivo retinal neurotoxicity

HR Watts, PJB Anderson, D Ma, et al

Eye and Brain 2010, 2:121-137

Published Date: 30 August 2010